Company
Angiotech Pharmaceuticals and Boston Scientific
Use
Paclitaxel-eluting stent used to prevent restenosis after ballon angioplasty of coronary peripheral arteries
Features
Largest 1st year sales of any FDA approved product in U.S. history
NIH Contribution
Discovered that localized release of paclitaxel prevents artery narrowing from cell growth
Success Stories
http://www.ott.nih.gov/pdfs/TaxusCS.pdf
Inventor(s)
J. Kinsella and S. Sollott